According to a market report by Lucintel, the future of the cell therapy technology market looks promising with opportunities in biopharmaceutical and biotechnology companies, CROs & CMOs, and research institutes & cell banks. The global cell therapy technology market is expected to reach an estimated $8.7 billion by 2028 with a CAGR of 14.5% from 2023 to 2028. The major drivers for this market are increasing investment by governments in cell-based research, rising cases of infection and skin & chronic diseases, and growing need for cell therapy clinical trials related to oncology treatments.
In this market, T-cell and stem cell are the two major segments by cell type. Lucintel forecasts that stem cell will remain the larger cell type segment over the forecast period due to the increasing need for therapies for neurological diseases and growing awareness of stem cell storage.
Within this market, research institutes and cell banks are expected to remain the largest end use industry segment due to the expanding research into treatments for illnesses of the lymphatic and nervous system.
North America will remain the largest region due to the existence of a strong regulatory environment to support the development of cellular therapies and an increase in research and development activities in the region.
Pharmicell, Corestem, Chiesi Farmaceutici, Tego Science, and Anterogen are the major suppliers in the global cell therapy technology market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global cell therapy technology market by product, process, cell type, end use industry, and region. Lucintel has compiled a comprehensive research report entitled “Growth Opportunities in the Global Cell Therapy Technology Market 2023-2028: Trends, Forecast, and Opportunity Analysis.” The Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global cell therapy technology market by product, process, cell type, end use industry, and region, as follows:
Cell Therapy Technology Market by Product [Value ($B) Shipment Analysis from 2017 to 2028]:
Media, Sera, and Reagents
Cell Engineering Products
Cell Culture Vessels
Cell Therapy Equipment
Cell Processing Equipment
Single-use Equipment
Other Equipment
Systems and Software
Others
Cell Therapy Technology Market by Process [Value ($B) Shipment Analysis from 2017 to 2028]:
Cell Processing
Cell Preservation
Distribution and Handling
Process Monitoring and Quality Control
Cell Therapy Technology Market by Cell Type [Value ($B) Shipment Analysis from 2017 to 2028]:
Cell Therapy Technology Market by End Use Industry [Value ($B) Shipment Analysis from 2017 to 2028]:
Biopharmaceutical and Biotechnology Companies
CROs and CMOs
Research Institutes and Cell Banks
Cell Therapy Technology Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:
North America
Europe
Asia Pacific
The Rest of the World
This more than 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or email us at
helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global
Management Consulting and market research firm, creates winning strategies for growth. Lucintel offers market assessments, competitive analysis, opportunity analysis,
Growth Consulting, M&A, and
Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit
www.lucintel.com.
This report answers the following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the cell therapy technology market by product (media, sera, and reagents, cell engineering products, cell culture vessels, cell therapy equipment, cell processing equipment, single-use equipment, systems and software, and others), process (cell processing, cell preservation, distribution and handling, and process monitoring and quality control), cell type (T-cell, stem cell, and others), end use industry (biopharmaceutical and biotechnology companies, CROs and CMOs, and research institutes and cell banks), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?